As a person living with type 1 diabetes who has been involved with T1International since 2019, I’m so proud to step into the role of Board Chair of Trustees this year. I believe in this organisation and this cause deeply because it is personal to me. I live with the ups and downs of diabetes, and I believe in health justice for everyone who is faced with this condition worldwide. Read more
I was diagnosed with type 1 diabetes in July of 2000. I had just finished my Primary School Education and was preparing to go to Uganda to pursue my Secondary and High School Education. l wasn't ready to use insulin. l think l was in denial. Read more
As we begin 2024 and think about the plans for T1International this year and beyond, I wanted to share a personal update that is also a big organisational update. After over a decade of leading T1International, the time has come for me to transition from my role as Executive Director by the end of 2024. This decision was not made lightly. Read more
The #insulin4all movement has had some major victories lately. For example, Medicare beneficiaries can access $35 copays for some insulins. The list price of insulin went down for nine insulins. Over half of the states in the USA have passed some form of insulin copay cap. These victories were hard fought by #insulin4all advocates over the past decade. But we’re not celebrating the much heralded $35 insulin cap for all. Because it’s not true.
Only eight days of National Diabetes Awareness Month had passed this November when pharmaceutical company Novo Nordisk announced it would be pulling Levemir, a long-acting insulin that millions of insulin-dependent diabetic patients depend on, from the U.S. market. Read more
The humanitarian crisis in Gaza is putting an extra burden on the already fragile state of diabetes management for all people with diabetes in the Strip. I had witnessed the situation myself many times before and contacted friends living with diabetes and healthcare professionals. I can assure you that people are suffering. Read more
To kick off Diabetes Awareness Month, the Global Diabetes compact held a two-day meeting where T1International and 35 other organisations in over 25 countries presented the goal of the Fight for Five campaign. We showed the depth and breadth of support for this campaign not only through stories of patients most impacted by lack of affordable and accessible insulin in their home countries, but also by the number of organisations that support a better world for people with diabetes. Read more
Mridula Kapil Bhargava began advocating to end diabetes stigma and for #insulin4all in 2015. As a Global Advocacy Partner representative of T1International (through Diabetes Fighters Trust) as well as a member of our Fight for Five Working Group, Mridula plays a huge role in our efforts to fight for a world where no one has to spend more than 5% of their average income for the insulin they need to survive and achieve their dreams. Read more
As I listened to the amazing sessions at this year's Summit, the rage from 2016 was still there, and rightly so, but there was also so much love, inclusivity and power. Whether you like the term 'patients' or not - we debated it at the Summit - this event was full of patients taking back their power. I was proud to be part of it and continue to be proud that T1International is making such a huge global impact as a small, pharma-free charity. Read more
Over the past few months, many insulin manufacturers and other entities have announced that they will be lowering the price of insulin in the United States. So, why is insulin still so expensive?
We recently released our Policy Playbook that goes through all of the details and gives advocates the information to push for change locally and nationally. Why insulin is so expensive can be boiled down to three main points. Read more